Free Trial

NexGel (NXGL) Competitors

NexGel logo
$2.36 -0.02 (-0.84%)
Closing price 07/25/2025 03:59 PM Eastern
Extended Trading
$2.37 +0.01 (+0.42%)
As of 07/25/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NXGL vs. SRTS, ZYXI, CTSO, RBOT, MDAI, SURG, ICCM, SPAI, EDAP, and QTI

Should you be buying NexGel stock or one of its competitors? The main competitors of NexGel include Sensus Healthcare (SRTS), Zynex (ZYXI), Cytosorbents (CTSO), Vicarious Surgical (RBOT), Spectral AI (MDAI), SurgePays (SURG), IceCure Medical (ICCM), Safe Pro Group (SPAI), Edap Tms (EDAP), and QT Imaging (QTI). These companies are all part of the "medical equipment" industry.

NexGel vs. Its Competitors

Sensus Healthcare (NASDAQ:SRTS) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

Sensus Healthcare has a net margin of 4.56% compared to NexGel's net margin of -30.80%. Sensus Healthcare's return on equity of 3.34% beat NexGel's return on equity.

Company Net Margins Return on Equity Return on Assets
Sensus Healthcare4.56% 3.34% 3.00%
NexGel -30.80%-54.95%-27.84%

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 8.9% of Sensus Healthcare shares are held by insiders. Comparatively, 20.6% of NexGel shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Sensus Healthcare has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, NexGel has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500.

Sensus Healthcare presently has a consensus price target of $11.67, suggesting a potential upside of 111.74%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, research analysts clearly believe Sensus Healthcare is more favorable than NexGel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sensus Healthcare
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
NexGel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Sensus Healthcare has higher revenue and earnings than NexGel. NexGel is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sensus Healthcare$41.81M2.17$6.65M$0.1055.10
NexGel$8.69M2.08-$3.28M-$0.45-5.24

In the previous week, Sensus Healthcare had 2 more articles in the media than NexGel. MarketBeat recorded 3 mentions for Sensus Healthcare and 1 mentions for NexGel. NexGel's average media sentiment score of 1.89 beat Sensus Healthcare's score of 0.47 indicating that NexGel is being referred to more favorably in the news media.

Company Overall Sentiment
Sensus Healthcare Neutral
NexGel Very Positive

Summary

Sensus Healthcare beats NexGel on 14 of the 16 factors compared between the two stocks.

Get NexGel News Delivered to You Automatically

Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NXGL vs. The Competition

MetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$18.19M$6.85B$5.70B$9.50B
Dividend YieldN/A1.27%4.60%4.01%
P/E Ratio-5.2425.4528.1020.06
Price / Sales2.0864.10429.3889.33
Price / CashN/A20.5536.2258.56
Price / Book2.624.758.665.87
Net Income-$3.28M$176.14M$3.25B$258.55M
7 Day Performance-2.48%2.92%4.22%3.73%
1 Month Performance-1.67%3.23%10.51%11.75%
1 Year Performance-24.84%7.28%34.40%18.02%

NexGel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NXGL
NexGel
0.8562 of 5 stars
$2.36
-0.8%
N/A-11.4%$18.19M$8.69M-5.2410Positive News
SRTS
Sensus Healthcare
1.1298 of 5 stars
$4.52
-1.7%
$11.67
+158.1%
-13.1%$74.66M$39.49M45.4040News Coverage
ZYXI
Zynex
2.143 of 5 stars
$2.44
+4.3%
$5.50
+125.4%
-74.7%$73.82M$192.35M-10.17770
CTSO
Cytosorbents
1.6634 of 5 stars
$1.06
+1.9%
$5.50
+418.9%
-8.4%$66.37M$35.60M-3.79220Gap Up
RBOT
Vicarious Surgical
0.3741 of 5 stars
$10.62
+3.3%
$8.50
-19.9%
+46.6%$62.95MN/A-1.02210Gap Down
MDAI
Spectral AI
3.5169 of 5 stars
$2.44
-0.2%
$4.75
+95.1%
+46.9%$61.65M$29.96M-4.5183
SURG
SurgePays
3.2901 of 5 stars
$2.98
+0.7%
$9.00
+202.0%
-2.0%$60.82M$60.88M-1.0740
ICCM
IceCure Medical
2.3314 of 5 stars
$0.99
-2.5%
$2.50
+152.5%
+33.8%$57.82M$3.29M-3.5260News Coverage
Gap Up
SPAI
Safe Pro Group
0.7136 of 5 stars
$3.80
+1.6%
$8.00
+110.5%
N/A$57.65M$2.17M-4.6911Positive News
Gap Down
EDAP
Edap Tms
3.0714 of 5 stars
$1.50
-1.0%
$8.50
+468.6%
-70.1%$55.90M$69.18M-2.41230
QTI
QT Imaging
N/A$1.98
-4.8%
N/A+194.2%$53.73M$4.00M0.00N/A

Related Companies and Tools


This page (NASDAQ:NXGL) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners